Hebrew University of Jerusalem Feb 3 2026 A new study examined whether providing financial vouchers to offset medication costs, conditional on improved blood sugar levels, could enhance glycemic control. The results demonstrated that participants receiving these performance-based incentives achieved a significantly larger reduction in HbA1c levels compared to a control group, an improvement clinically comparable to adding a new pharmacological treatment. Based on these findings, the authors